Association of Prior Antithrombotic Drug Use with 90-Day Mortality After Intracerebral Hemorrhage
In this unselected cohort from a geographically defined Danish population, 90-day mortality after s-ICH was higher in patients with prior use of an OAC compared with no AT use or patients using a PA. Mortality was slightly lower for patients using a DOAC than a VKA. Mortality was also higher in PA- vs no AT-users, but there were no differences in mortality between clopidogrel vs aspirin.
Authors
- Luis A. Garcı́a Rodrı́guez (ORCID: https://orcid.org/0000-0003-0837-2709)
- Mie Micheelsen Jensen (ORCID: https://orcid.org/0000-0002-8118-2576)
- Nils Jensen Boe (ORCID: https://orcid.org/0000-0002-6813-8415)
- David Gaist (ORCID: https://orcid.org/0000-0001-5205-7007)
- Mohammad Talal Elhakim (ORCID: https://orcid.org/0000-0002-2673-2352)
- Rustam Al‐Shahi Salman (ORCID: https://orcid.org/0000-0002-2108-9222)
- Frederik Severin Gråe Harbo (ORCID: https://orcid.org/0000-0002-2644-8263)
- Stine Munk Hald (ORCID: https://orcid.org/0000-0003-1600-1684)
- Magdy Selim (ORCID: https://orcid.org/0000-0002-1936-3173)
- Christian Ovesen (ORCID: https://orcid.org/0000-0002-4870-4475)
- Jonas Asgaard Bojsen (ORCID: https://orcid.org/0000-0003-1603-462X)
- Larry B. Goldstein (ORCID: https://orcid.org/0000-0001-7747-128X)
- Birgit Bjerre Høyer (ORCID: https://orcid.org/0000-0002-0676-2685)
- Christian Jørgensen
- Jesper Hallas (ORCID: https://orcid.org/0000-0002-8097-8708)
- Frederik Meyer-Kristensen
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of Kentucky (US)
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Bispebjerg Hospital (DK)
- Centro Español de Investigación Farmacoepidemiológica (ES)
- University of Edinburgh (GB)
Publication Details
- Journal
- Clinical Epidemiology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/clep.s493499
- Citations
- 3
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- Lundbeckfonden
- Novo Nordisk
- Novo Nordisk Fonden
- H. Lundbeck A/S